Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies

Mycopathologia

Volumn 166, Issue 1, 2008, Pages 47-50

  Savini, Vincenzo ^a   Catavitello, Chiara ^a   Manna, Assunta ^a   Talia, Marzia ^a   Febbo, Fabio ^a   Balbinot, Andrea ^a   D'Antonio, Francesco ^b   Di Bonaventura, Giovanni ^b   Celentano, Claudio ^b   Liberati, Marco ^b   Piccolomini, Raffaele ^b   D'Antonio, Domenico ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Azoles; Saccharomyces cerevisiae; Vaginitis

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ADULT; ANTIFUNGAL RESISTANCE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MYCOSIS; PATHOGENICITY; REVIEW; SACCHAROMYCES CEREVISIAE; VAGINA CANDIDIASIS; VAGINITIS; VULVOVAGINITIS;

ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS, VULVOVAGINAL; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; ITRACONAZOLE; MIDDLE AGED; MYCOSES; SACCHAROMYCES CEREVISIAE; VAGINITIS; VULVOVAGINITIS;

CANDIDA; SACCHAROMYCES CEREVISIAE;

EID: 46249094427     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-008-9119-y     Document Type: Review

References (39)

1. Passos XS, Costa CR, Araujo CR, Nascimento ES, e Souza LK, Fernandes Ode F, Sales WS, Silva Mdo R. Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital. Mycopathologia. 2007;163(3):145-51.
2. Zerva L, Hollis RJ, Pfaller MA. In vivo susceptibility and DNA typing of Saccharomyces cerevisiae clinical isolates. J Clin Microb. 1996;34(2):3031-4.
3. McCullough MJ, Clemons KV, Farina C, McCusker JH, Stevens DA. Epidemiological investigation of vaginal Saccharomyces cerevisiae isolates by a genotypic method. J Clin Microb. 1998;36(2):557-62.
4. Garcia-Martos P, Mira J, Galan F, Hernandez JM. Sexual forms of yeasts in clinical samples. Mycopathologia. 1996-1997;136(2):67-70.
5. Sobel JD, Vaquez J, Lynch M, Meriwether C, Zervos MJ. Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects, and therapy. Clin Infect Dis. 1993;16:93-9.
6. Figuereido VT, de Assis Santos D, Resende MA, Hamdan JS. Identification and in vivo antifungal susceptibility testing of 2000 clinical isolates of Candida spp. responsible for fingernail infections. Mycopathologia. 2007;164(1):27-33.
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts. Approved standard M27-A2. 2nd ed. Wayne: National Committee for Clinical Laboratory Standards; 2002.
8. Clemons KV, McCusker JH, Davis RW, Stevens DA. Comparative pathogenesis of clinical and nonclinical isolates of Saccharomyces cerevisiae. J Infect Dis. 1994;169:859-67.
9. McCusker JH, Clemons KV, Stevens DA, Davis RW. Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice, is associated with the ability to grow at 42°C and form pseudohyphae. Infect Immun. 1994;62:5447-55.
10. Munoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Pérez MJ, Sánchez-Somolinos M, Rincón C, Hortal J, Peláez T. Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40(11):1625-34.
11. Kusumaningtyas E, Widiastuti R, Maryam R. Reduction of aflatoxin B1 in chicken feed by using Saccharomyces cerevisiae, Rhizopus oligosporus and their combination. Mycopathologia. 2006;162(4):307-11.
12. de Resende MA, Alterthum F. Effect of nystatin, amphotericin B and amphotericin B methyl ester on Saccharomyces cerevisiae with different lipid composition. Mycopathologia. 1990;112(3):165-72.
13. Evans EGV, Richardson MD. Medical mycology: a practical approach. Oxford (UK): IRL Press; 1989.
14. Larone DH. Medically important fungi-a guide to identification. 3rd ed. Washington: ASM Press; 1995.
15. Fiol JB. Systematic studies of Saccharomyces: oxidases and vitamin requirements. Mycopathologia. 1976;58(1):49-58.
16. Kurtzman CP, Smiley MJ, Baker FL. Scanning electron microscopy of ascospores of Debaryomyces and Saccharomyces. Mycopathologia. 1975;55(1):29-34.
17. Siccardi D, Rellini P, Corte L, Bistoni F, Fatichetti F, Cardinali G. General evidence supporting the hypothesis that Saccharomyces cerevisiae vaginal isolates originate from food industrial environments. New Microbiol. 2006;29(3):201-6.
18. Iwata K. Fungal toxins as a parasitic factor responsible for the establishment of fungal infections. Mycopathologia. 1978;65(1-3):141-54.
19. Mancianti F, Nardoni S, Ceccherelli R. Occurrence of yeasts in psittacines droppings from captive birds in Italy. Mycopathologia. 2002;153(3):121-4.
20. Papavassiliou JT, Bartzokas CA. The atmospheric fungal flora of the Athens metropolitan area. Mycopathologia. 1975;57(1):31-4.
21. Aucott JN, Fayen J, Grossnicklas H, Morrissey A, Lederman MM, Salata RA. Invasive fungal infection with Saccharomyces cerevisiae: report of three cases and review. Rev Infect Dis. 1990;12:406-11.
22. Belet N, Dalgic N, Oncel S, Ciftci E, Guriz H, Barlas M, Dogru U. Catheter-related fungemia by Saccharomyces cerevisiae in a newborn. Pediatr Infect Dis J. 2005;24(12):1125.
23. De Llanos R, Querol A, Peman J, Gobernado M, Fernandez-Espinar MT. Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. Int J Food Microbiol. 2006;110(3):286-90.
24. Enache-Angoulvant A, Hennequin C. Invasive Saccharomyces cerevisiae infection: a comprehensive review. Clin Infect Dis. 2005;41(11):1559-68.
25. Williams JS, Mufti GJ, Powell S, Salisbury JR, Higgins EM. Saccharomyces cerevisiae emboli in an immunocompromised patient with relapsed myeloid leukemia. Clin Exp Dermatol. 2007;32(4):395-7.
26. Barefoot SF, Klaenhammer TR. Detection and activity of lactacin B, a bacteriocin produced by Lactobacillus acidophilus. Appl Environ Microbiol. 1983;45:1808-15.
27. Galask RP. Vaginal colonization by bacteria and yeasts. Am J Obstet Gynecol. 1989;158:993-5.
28. Consolaro ME, Gasparetto A, Svidzinski TI, Peralta RM. Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions. Mycopathologia. 2006;162(2):75-82.
29. Lehrer N, Segal E, Lis H, Gov Y. Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa. Mycopathologia. 1988;102(2):115-21.
30. Lopez-Martinez R, Ruiz-Sanchez D, Vertiz-Chavez E. Vaginal candidiasis. Opportunistic factors and clinical correlation in 600 patients. Mycopathologia. 1984;85(3):167-70.
31. Marcano C, Feo M. Effectiveness of econazole on pregnant women with vulvo-vaginal candidiasis. Mycopathologia. 1983;81(2):65-70.
32. Warnock DW, Milne JD, Fielding AM. Immunoglobulin classes of human serum antibodies in vaginal candidiasis. Mycopathologia. 1978;63(3):173-5.
33. Bulmer GS, Marquez ML, Co-Barcelona L, Fromtling RA. Yeasts and fluconazole susceptibility in the Philippines. Mycopathologia. 1999;146(3):117-20.
34. Candido RC, Toloi MR, Franceschini SA, Garcia FR, Minto EC. In vivo activity of antimycotic agents determined by E-test method against vaginal Candida species. Mycopathologia. 1998-1999;144(1):15-20.
35. Costa M, Passos XS, Miranda AT, de Araujo RS, Paula CR, Silva Mdo R. Correlation of in vivo itraconazole and fluconazole susceptibility with clinical outcome for patients with vulvovaginal candidiasis. Mycopathologia. 2004;157(1):43-7.
36. Ribeiro MA, Dietze R, Paula CR, Da Matta DA, Colombo AL. Susceptibility profile of vaginal yeast isolates from Brazil. Mycopathologia. 2001;151(1):5-10.
37. Ringel SM. New antifungal agents for the systemic mycoses. Mycopathologia. 1990;109(2):75-87.
38. Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia. 2004;157(2):163-9.
39. Hussain Qadri SM, Flournoy DJ, Qadri SG, Ramirez EG. Susceptibility of clinical isolates of yeasts to anti-fungal agents. Mycopathologia. 1986;95(3):183-7.